1. Market Research
  2. > Chronic Disease Industry

Heart Failure Industry, January 2017 Market Reports from Top Publishers

You might be interested in: Cardiovascular Disease, Cardiac Management, Therapy, Cardiac Monitoring, Interventional Cardiology Device, Biomarker, Prosthesis, Cardiology, Hemodynamic Monitor, Nursing Home, Point Of Care Testing, Surgery, Cardiovascular Drug, Diagnostics, Healthcare, Hypertension, Salt, Stem Cell, Transdermal Delivery, Anesthesia Equipment.


 
1-10 of 50 reports for Heart Failure

Purchase Reports From Reputable Market Research Publishers

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 754
  • Industry report
  • Jan 2017
  • by Firstword Pharma

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. ...

Acute heart failure (AHF) - Epidemiology Forecast To 2023

Acute heart failure (AHF) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Acute heart failure (AHF) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Acute heart failure (AHF) in seven major markets (US, France, Germany, Italy, ...

 Acute Heart Failure-Pipeline Insights, 2017

Acute Heart Failure-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Acute Heart Failure-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Acute Heart Failure. The Del ...

Chronic Heart Failure - Epidemiology Forecast To 2023

Chronic Heart Failure - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Chronic Heart Failure - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Chronic Heart Failure in seven major markets (US, France, Germany, Italy, Spain, ...

 Chronic Heart Failure-Pipeline Insights, 2017

Chronic Heart Failure-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Chronic Heart Failure-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Chronic Heart Failure. The ...

Diastolic Heart Failure Global Clinical Trials Review, H2, 2016

Diastolic Heart Failure Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Diastolic Heart Failure Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Diastolic Heart Failure Global Clinical Trials Review, H2, 2016" provides an overview of Diastolic ...

Global Congestive Heart Failure Partnering 2010 to 2016

Global Congestive Heart Failure Partnering 2010 to 2016

  • $ 1495
  • Industry report
  • November 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - ...

Global Congestive Heart Failure (CHF) Treatment Market Research Report 2016

Global Congestive Heart Failure (CHF) Treatment Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Congestive Heart Failure (CHF) Treatment Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Congestive Heart Failure (CHF) ...

Congestive Heart Failure (CHF) Treatment Devices Market Analysis by Product (Ventricular Assist Devices, Counter Pulsation Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization Therapy) And Segment Forecasts to 2024

Congestive Heart Failure (CHF) Treatment Devices Market Analysis by Product (Ventricular Assist Devices, Counter Pulsation Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization Therapy) And Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • October 2016
  • by Grand View Research

The congestive heart failure (CHF) treatment devices market is expected to reach USD 32.0 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the ...

Chronic Heart Failure - Pipeline Review, H2 2016

Chronic Heart Failure - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Chronic Heart Failure - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Heart Failure - Pipeline Review, H2 2016, provides an ...

About 10000 reports for Heart Failure

Download Unlimited Documents from Trusted Public Sources

Protein Analysis in the US

  • January 2015
    269 pages
  • Protein  

    Heart Failure  

    Biomarker  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.